Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/22/2010 | EP2263691A1 Treatment of cancer with the recombinant humanized monoclonal anti-erbb2 antibody 2C4 (rhuMAb 2C4) |
12/22/2010 | EP2263690A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof |
12/22/2010 | EP2263689A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof |
12/22/2010 | EP2263686A1 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
12/22/2010 | EP2263684A1 IL-21 derivatives |
12/22/2010 | EP2262914A1 Methods and kits for detecting congenital stationary night blindness and selecting different coat patterns |
12/22/2010 | EP2262831A1 Anti-properdin antibodies |
12/22/2010 | EP2262830A2 Cellular differentiation promotion |
12/22/2010 | EP2262829A1 A new type of consensus interferon and preparation method thereof |
12/22/2010 | EP2262828A1 Compositions, methods and kits |
12/22/2010 | EP2262827A1 Production of itaconic acid |
12/22/2010 | EP2262826A1 Production of itaconic acid |
12/22/2010 | EP2262825A2 Process to produce fibrillar proteins and method of treating using fibrillar proteins |
12/22/2010 | EP2262540A2 Latency associated protein construct with aggrecanase sensitive cleavage site |
12/22/2010 | EP2262539A1 Insulin albumin conjugates |
12/22/2010 | EP2262533A1 Screening method for agents suitable for prophylaxis and therapy of alzheimer's disease (ad) |
12/22/2010 | EP2262526A1 Stable amyloid beta monomers and oligomers |
12/22/2010 | EP2262489A2 Hollow nanoparticles and uses thereof |
12/22/2010 | EP2054440B1 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin alpha5beta1, having proangiogenic activity |
12/22/2010 | EP1664289B1 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
12/22/2010 | EP1626983B8 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof |
12/22/2010 | EP1596879B1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
12/22/2010 | EP1561814B1 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
12/22/2010 | EP1558760B1 Crh responsive genes in cns |
12/22/2010 | EP1549338B1 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
12/22/2010 | EP1419171B1 Methods for the synthesis of a modified hemoglobin solution |
12/22/2010 | EP1135496B1 Ucp5 |
12/22/2010 | EP1019077B2 Novel exendin agonist compounds |
12/22/2010 | CN1836047B Methods for the production of insulin in plants |
12/22/2010 | CN1824677B Splicing isomer of human interleukin 23 specificity acceptor, its coding gene and application |
12/22/2010 | CN1809638B Method of detecting beta 3 adrenaline receptor mutant gene and nucleic acid probe and kit therefor |
12/22/2010 | CN1481390B Immunomodulatory peptides derived from heat shock proteins and uses thereof |
12/22/2010 | CN101921799A Preparation method of horse serum amyloid protein A1 and expression vector and genetic engineering bacteria thereof |
12/22/2010 | CN101921793A Human apolipoprotein AI genetic engineering preparation method and expression vector and engineering bacteria thereof |
12/22/2010 | CN101921781A Xinjiang hemorrhagic fever virus nucleoprotein antigen gene as well as recombinant protein and application thereof |
12/22/2010 | CN101921779A Gene DvCRP2 with Cd2+ resistant and Cu2+ resistant functions, encoding protein and application thereof |
12/22/2010 | CN101921778A Gene DvCRP1 with Cd<2+> and Cu<2+> resistance as well as coding protein and application thereof |
12/22/2010 | CN101921776A Brassica napus disease-resistance related gene BnERF56 and application thereof |
12/22/2010 | CN101921774A Application of Dnaj-like protein and encoded gene thereof |
12/22/2010 | CN101921768A Schistosoma japonica 14-3-3 protein gene, coded protein thereof and application thereof |
12/22/2010 | CN101921767A Schistosoma japonica MF3 protein gene, and coding protein and application thereof |
12/22/2010 | CN101921756A Soybean flowering regulator gene GmCIB8 as well as coded protein and application thereof |
12/22/2010 | CN101921755A Soybean blossoming regulation gene GmCIB3, coding protein and application thereof |
12/22/2010 | CN101921754A Soybean blossoming regulation gene GmCIB4, coding protein and application thereof |
12/22/2010 | CN101921753A Soybean blossoming regulator gene GmCIB5, encoding protein and application thereof |
12/22/2010 | CN101921752A Soybean flowering regulatory gene GmCIB6, encoding protein and application thereof |
12/22/2010 | CN101921732A A virus causing respiratory tract illness in susceptible mammals |
12/22/2010 | CN101921333A Method for preparing high-coupling-rate lead antigen by improved glutaraldehyde method |
12/22/2010 | CN101921332A Recombinant human insulin and production method thereof |
12/22/2010 | CN101921331A Method for preparing thymosin |
12/22/2010 | CN101921330A Recombinant human interferon alpha 1b mutant and preparation method thereof |
12/22/2010 | CN101921329A Alpha interferon mutant and polyethylene glycol derivative thereof |
12/22/2010 | CN101921328A Antifreeze polypeptide prepared by enzymolysis of cow leather collagen by alkali protease |
12/22/2010 | CN101921327A Protein and coding gene and suicide vector thereof |
12/22/2010 | CN101921326A Recombinant decorsin mutant, preparation method and application thereof |
12/22/2010 | CN101921325A Antigen capable of increasing CD4 + CD25 + Foxp3 + regulatory T cells and application thereof |
12/22/2010 | CN101921324A Alba plastein C9orf23 protein of human and use in self autoimmune hepatitis diagnosis |
12/22/2010 | CN101921323A Human protein (ribosomal protein S20) and use thereof in diagnosis of autoimmune hepatitis |
12/22/2010 | CN101921322A Chrysanthemum photoperiod-sensitive gene and application thereof |
12/22/2010 | CN101921321A Protein IPA1 relevant with plant types and coding gene and applications thereof |
12/22/2010 | CN101921320A Separation and purification method of recombinant proteins A |
12/22/2010 | CN101920012A Method for producing porcine circovirus type II recombinant capsid protein subunit vaccine by utilizing silkworm bioreactor and products thereof |
12/22/2010 | CN101920008A Preparation containing Abeta 40 polypeptide and aluminum adjuvant and method for purifying Abeta 40 polypeptide |
12/22/2010 | CN101920006A Cyclin Y and use thereof |
12/22/2010 | CN101920004A Preparation and application of coconut globulin ferrous complex iron supplement agent |
12/22/2010 | CN101418295B Biosensor and use thereof |
12/22/2010 | CN101348769B H+-ATP enzyme acid resistant gene atpA' and Lactobacillus casei containing the same |
12/22/2010 | CN101289507B Collagen protein and collagen polypeptides, preparation thereof and applications |
12/22/2010 | CN101273129B Recombinant vector capable of increasing secretion of koji mold protease |
12/22/2010 | CN101270158B Target glioma resistant protein, preparation method and application |
12/22/2010 | CN101191130B ChIFNGR1 gene and its coding protein and application |
12/21/2010 | US7855328 Defensin polynucleotides and methods of use |
12/21/2010 | US7855327 Crop plants with disease resistance against fungal pathogens such as Colletotrichum graminicola, Diplodia maydis, Fusarium graminearum, and Fusarium moniliforme, or nematodes |
12/21/2010 | US7855324 Transgenic freeze and drought resistant plants; crops with enhanced resistance to enviromental stresses; plant transformed by a Protein Kinase Stress-Related Protein (PKSRP) coding nucleic acid |
12/21/2010 | US7855282 Protein, a gene encoding therefor and a method of using the same |
12/21/2010 | US7855280 separating a solid from a target protein by forming a solid containing a cation and an anion in a medium containing a protein, and separating the solid from the protein |
12/21/2010 | US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy |
12/21/2010 | US7855277 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis |
12/21/2010 | US7855274 Recombinant factor VIII having increased specific activity |
12/21/2010 | US7855273 Using thin-film with molecular weight cut-off to isolate gelatin molecules for use in preparing bioscaffolds; tissue engineering; regenerative medicine |
12/21/2010 | US7855272 Fibrinogen binding protein for use in diagnosis, prevention and treatment of Staphylococcal infection; bactericides |
12/21/2010 | US7855271 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
12/21/2010 | US7855270 Genetically engineered receptor for use in the detection and analysis of protein binding activity |
12/21/2010 | US7855269 Down-regulating IL-19 comprising administering to an individual a polypeptide comprised of the extracellular domain of IL-20RA and the extracellular domain of IL-20RB. |
12/21/2010 | US7855268 Tolerogizing compositions comprising botulinum toxin type B peptides |
12/21/2010 | US7855182 Using glypican 5 antagonist as therapeutic in treatment of mammary gland cell proliferative disorders |
12/21/2010 | US7855178 antagonizing the function of vascular endothelial growth factor (VEGF) receptors, platelet derived growth factor (PDGF) receptors and other receptors; for inhibition of aberrant angiogenesis and lymphangiogenesis, and inhibition of other effects of members of the PDGF/VEGF family of growth factors |
12/21/2010 | US7855175 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production; anemia; genetic discorder; blood disorders; erythropoietin receptor agonists |
12/21/2010 | US7855167 In vivo screening of protein-protein interactions with protein-fragment complementation assays |
12/21/2010 | US7855076 Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway |
12/21/2010 | US7855072 System for detecting protease |
12/21/2010 | US7855066 the ions include zinc and cobalt which improve Apo-2 ligand trimer formation and stability; tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) |
12/21/2010 | US7855060 Transgenic escherichia for use as bioreactor for fermentation of amino acids for use in medicine, cosmetics and animal feeds |
12/21/2010 | US7855052 sequences from the Core/E1 region of HCV type 3; detection of HCV infection |
12/21/2010 | US7854937 Flavivirus fusion inhibitors |
12/21/2010 | US7854934 For treatment of cancer, preferably for prevention of recurrence of cancer, and for inducing antibodies in subject by administering glycopeptides |
12/21/2010 | US7854931 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
12/21/2010 | CA2523297C Inhibitor screening method and atopic dermatitis-like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte, and utilization of same |
12/21/2010 | CA2490724C Method for the diagnosis and prognosis of malignant diseases |
12/21/2010 | CA2468374C Glp-1 derivatives |